Publikationen der ABCSG 2023-2021

Finden Sie hier eine Übersicht zu peer-reviewed Fachpublikationen (Vollpublikationen), an denen die ABCSG maßgeblich beteiligt war


Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

Kerstin Wimmer, Monika Sachet, Cristiano Ramos, Sophie Frantal, Hanna Birnleitner, Christine Brostjan, Ruth Exner, Martin Filipits, Zsuzsanna Bago-Horvath, Margaretha Rudas, Rupert Bartsch, Michael Gnant, Christian F. Singer, Marija Balic, Daniel Egle, Rudolf Oehler & Florian Fitzal 

Journal of Experimental & Clinical Cancer Research volume 42, Article number: 300 (2023) 
Published: 14 November 2023

ASO Visual Abstract: Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Walter P. Weber MD, Martin Heidinger MD, Stefanie Hayoz PhD, Zoltan Matrai MD, PhD, Christoph Tausch MD, Guido Henke MD, Daniel R. Zwahlen MD, Günther Gruber MD, Frank Zimmermann MD, Giacomo Montagna MD, MPH, Mariacarla Andreozzi PhD, Maite Goldschmidt MSc, Alexandra Schulz MSc, Andreas Mueller MD, Markus Ackerknecht PhD, Ekaterini Christina Tampaki MD, PhD, Vesna Bjelic-Radisic MD, Christian Kurzeder MD, Ákos Sávolt MD, PhD, Viktor Smanykó MD, Daniela Hagen MD, Dieter J. Müller MD, Michael Gnant MD, Sibylle Loibl MD, Florian Fitzal MD, Pagona Markellou MD, Inga Bekes MD, Daniel Egle MD, Jörg Heil MD & Michael Knauer MD, PhD 

Annals of Surgical Oncology (2023)
Published: 13 November 2023

Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer

Maximilian Marhold, Simon Udovica, Anna Halstead, Mona Hirdler, Muna Ferner, Kerstin Wimmer, Zsuzsanna Bago-Horvath, Ruth Exner, Florian Fitzal, Kathrin Strasser-Weippl, Tim Robinson & Rupert Bartsch

Published online: 13 November  2023

Patient-reported outcomes in high-risk HR+/HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study

José Angel García-Sáenz, Frederik Marmé, Michael Untch, Hervé Bonnefoi, Sung-Bae Kim, Harry Bear, Nicole Mc Carthy, Karen Gelmon, Miguel Martin, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Ernest Law, Helen Bhattacharyya, Michael Gnant, Andreas Makris, Sabine Seiler, Nicole Burchardi, Valentina Nekljudova, Sibylle Loibl, Hope S. Rugo

European Journal of Cancer
Published: November 5th, 2023

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)

Lancet 2023; 401: 1277–92
Open Access, Published: November 03, 2023

Impact of Imaging‑Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node‑Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC‑03, SAKK 23/16, IBCSG 57‑18, ABCSG‑53, GBG 101

Walter P. Weber, MD, Martin Heidinger, MD, Stefanie Hayoz, PhD , Zoltan Matrai, MD, PhD , Christoph Tausch, MD, Guido Henke, MD, Daniel R. Zwahlen, MD , Günther Gruber, MD , Frank Zimmermann, MD, Giacomo Montagna, MD, MPH, Mariacarla Andreozzi, PhD, Maite Goldschmid, Alexandra Schulz, Andreas Mueller, MD, Markus Ackerknecht, PhD, Ekaterini Christina Tampaki, MD, PhD, Vesna Bjelic‑Radisic, MD, Christian Kurzeder, MD, Ákos Sávolt, MD, PhD, Viktor Smanykó, MD, Daniela Hagen, MD, Dieter J. Müller, MD, Michael Gnant, MD, Sibylle Loibl, MD, Florian Fitzal, MD, Pagona Markellou, MD , Inga Bekes, MD , Daniel Egle, MD, Jörg Heil, MD, and Michael Knauer, MD, PhD

Annals of Surgical Oncology
DOI: 10.1245/s10434-023-14404-4
Published 30 October 2023

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study

Gudrun Piringer, Thomas Grienberger, Josef Thaler et al.,
Frontiers in Oncology, 09.08.2023

Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer

Walter P. Weber, MD; Zoltan Matrai, MD, PhD; Stefanie Hayoz, PhD; et al
von ABCSG-Seite als Co-Autoren vertreten sind F. Fitzal, M. Gnant, D. Egle

JAMA Surg. Published online July 19, 2023. doi:10.1001/jamasurg.2023.2840

Trends in use of neoadjuvant systemic therapy in patients with clinically node‑positive breast cancer in Europe: prospective TAXIS study (OPBC‑03, SAKK 23/16, IBCSG 57‑18, ABCSG‑53, GBG 101)

Tausch et al
von ABCSG-Seite als Co-Autoren vertreten sind F. Fitzal, M. Gnant, D. Egle, C. Hager. K. Reisenberger, C. Singer

Breast Cancer Res Treat. 2023; 201(2): 215–225.
Published online 2023 Jun 25. doi: 10.1007/s10549-023-06999-9

Impact of BMI in Patients With Early Hormone Receptor–Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial

Georg Pfeiler, Dominik Hlauschek, Erica L. Mayer  et al

DOI: 10.1200/JCO.23.00126 Journal of Clinical Oncology

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
C Fesl, M Gnant, L Sölkner, G G Steger (Groups (lead investigators) contributing data)

Lancet 2023 Apr 15;401(10384):1277-1292.doi: 10.1016/S0140-6736(23)00285-4

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H. Partridge, M.D., M.P.H., Samuel M. Niman, M.S., Monica Ruggeri, Fedro A. Peccatori, M.D., Ph.D., Hatem A. Azim, Jr., M.D., Ph.D., Marco Colleoni, M.D., Cristina Saura, M.D., Ph.D., Chikako Shimizu, M.D., Anna B. Sætersdal, M.D., Judith R. Kroep, M.D., Ph.D., Audrey Mailliez, M.D., Ellen Warner, M.D., et al., for the International Breast Cancer Study Group, and the POSITIVE Trial Collaborators†

The New England Journal of Medicine
N Engl J Med 2023; 388:1645-1656
DOI: 10.1056/NEJMoa2212856

IBCSG 48-14

Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12

Ana-Alicia Beltran-Bless Mark J. Clemons Christian Fesl Richard Greil Gregory R. Pond Marija Balic Lisa Vandermeer Vesna Bjelic-Radisic Christian F. Singer Guenther G. Steger Ruth Helfgott Daniel Egle Lidija Sölkner Simon P. Gampenrieder Stephanie Kacerovsky-Strobl Christoph Suppan Magdalena Ritter Gabriel Rinnerthaler Georg Pfeiler Hannes Fohler Dominik Hlauschek John Hilton Michael Gnant

European Journal of Cancer 180 (2023), 108-116, DOI:


Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer

Michael Gnant, M.D.1,2, Sophie Frantal, M.Sc.2, Georg Pfeiler, M.D.3, Guenther G. Steger, M.D.,4, Daniel Egle, M.D.5, Richard Greil, M.D.6, Florian Fitzal, M.D.7, Viktor Wette, M.D.8, Marija Balic, M.D.9, Ferdinand Haslbauer, M.D.10, Elisabeth Melbinger-Zeinitzer, M.D.11, Vesna Bjelic-Radisic, M.D.12,13, Silvia Artner-Matuschek, M.D.14, Franz Kainberger, M.D.15, Magdalena Ritter, M.D.5, Gabriel Rinnerthaler, M.D.6, Paul Sevelda, M.D.16, Jonas Bergh, M.D.17, Stephanie Kacerovsky-Strobl, M.D.7,18, Christoph Suppan, M.D.9, Christine Brunner, M.D.5, Christine Deutschmann, M.D.3, Simon P. Gampenrieder, M.D.6, Hannes Fohler, M.V.M.2, Raimund Jakesz, M.D.7, Christian Fesl, Ph.D.2, and Christian Singer, M.D.3for the Austrian Breast & Colorectal Cancer Study Group*

NJEM Evidence, November 2022, Vol.1 No.12, DOI:

Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer

Christian F. Singer, for the ABCSG; Frederik Holst, Stefan Steurer , Eike C. Burandt , Sigurd F. Lax, Raimund Jakesz , Margaretha Rudas , Herbert Stoger , Richard Greil ,for the ABCSG; Guido Sauter, Martin Filipits, for the ABCSG, Ronald Simon, and Michael Gnant; for the ABCSG

Clinical Cancer Research, ePub August 2022, DOI: 10.1158/1078-0432.CCR-21-4328.

Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy.

Weber WP, Shaw J, Pusic A, Wyld L, Morrow M, King T, Mátrai Z, Heil J, Fitzal F, Potter S, Rubio IT, Cardoso MJ, Gentilini OD, Galimberti V, Sacchini V, Rutgers EJT, Benson J, Allweis TM, Haug M, Paulinelli RR, Kovacs T, Harder Y, Gulluoglu BM, Gonzalez E, Faridi A, Elder E, Dubsky P, Blohmer JU, Bjelic-Radisic V, Barry M, Hay SD, Bowles K, French J, Reitsamer R, Koller R, Schrenk P, Kauer-Dorner D, Biazus J, Brenelli F, Letzkus J, Saccilotto R, Joukainen S, Kauhanen S, Karhunen-Enckell U, Hoffmann J, Kneser U, Kühn T, Kontos M, Tampaki EC, Carmon M, Hadar T, Catanuto G, Garcia-Etienne CA, Koppert L, Gouveia PF, Lagergren J, Svensjö T, Maggi N, Kappos EA, Schwab FD, Castrezana L, Steffens D, Krol J, Tausch C, Günthert A, Knauer M, Katapodi MC, Bucher S, Hauser N, Kurzeder C, Mucklow R, Tsoutsou PG, Sezer A, Çakmak GK, Karanlik H, Fairbrother P, Romics L, Montagna G, Urban C, Walker M, Formenti SC, Gruber G, Zimmermann F, Zwahlen DR, Kuemmel S, El-Tamer M, Vrancken Peeters MJ, Kaidar-Person O, Gnant M, Poortmans P, de Boniface J.

The Breast, March 2022, DOI: 10.1016/j.breast.2022.03.008.

Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18.

Minichsdorfer C, Fuereder T, Leutner M, Singer CF, Kacerovsky-Strobl S, Egle D, Greil R, Balic M, Fitzal F, Pfeiler G, Frantal S, Bartsch R, Gnant M.

ESMO Open, March 2022. DOI: 10.1016/j.esmoop.2022.100426.

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)

The Lancet Oncology, March 2022, DOI: 10.1016/S1470-2045(21)00758-0

Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic

Georg Pfeiler, Angela DeMichele, Amylou C. Dueck, Christian Fesl, Michael Gnant, Erica L. Mayer

The Lancet Oncology, 2 February 2022; DOI:

Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)

Mayer E L, Fesl C, Hlauschek D, Garcia-Estevez L, Burstein H J, Zdenkowski N, Wette V, Miller K D, Balic M, Mayer I A, Cameron D, Winer E P, Ponce Lorenzo J J, Lake D, Pristauz-Telsnigg G, Haddad T C, Shepherd L, Iwata H, Goetz M, Cardoso F, Traina TA, Sabanathan D, Breitenstein U, Ackerl K, Metzger Filho O,  Zehetner K, Solomon K, El-Abed S, Theall K P, Lu D R, Dueck A, Gnant M, DeMichele A.

Journal of Clinical Oncology, 07 January 2022, DOI: 10.1200/JCO.21.01918


Persistence of ctDNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumour response 

Qing Zhou, Simon P. Gampenrieder, Sophie Frantal ,Gabriel Rinnerthaler, Christian F. Singer , Daniel Egle, Georg Pfeiler, Rupert Bartsch, Viktor Wette, Angelika Pichler  , Edgar Petru, Peter C. Dubsky , Zsuzsanna Bago-Horvath, Christian Fesl , Margaretha Rudas , Anders Ståhlberg, Ricarda Graf , Sabrina Weber, Nadia Dandachi, Martin Filipits , Michael Gnant , Marija Balic, Ellen Heitzer on behalf of the 7 ABCSG

American Association for Cancer Research, December 3, 2021; DOI: 10.1158/1078-0432

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/ original reports AFT-05/BIG-14-03)

 Michael Gnant, MD; Amylou C. Dueck, PhD; Sophie Frantal, MSc; Miguel Martin, MD ; Hal J. Burstein, MD ; Richard Greil, MD; Peter Fox, MBBS; Antonio C. Wolff, MD; Arlene Chan, MMed; Eric P. Winer, MD; Georg Pfeiler, MD; Kathy D. Miller, MD; Marco Colleoni, MD; Jennifer M. Suga, MD; Gabor Rubovsky, PhD; Judith M. Bliss, MSc; Ingrid A. Mayer, MD; Christian F. Singer, MD; Zbigniew Nowecki, MD; Olwen Hahn, MD; Jacqui Thomson, MBBS; Norman Wolmark, MD; Kepa Amillano, MD; Hope S. Rugo, MD; Guenther G. Steger, MD; Blanca Hernando Fern ´andez de Ar ´anguiz, MD 5,24 ; Tufia C. Haddad, MD 25 ; Antonia Perell ´o, MD 26 ; Meritxell Bellet, MD; Hannes Fohler, MVM; Otto Metzger Filho, MD; Anita Jallitsch-Halper, PhD 2 ; Kadine Solomon, BA; C´eline Schurmans, MSc; Kathy P. Theall, MD; Dongrui R. Lu, MS; Kathleen Tenner, MSc; Christian Fesl, PhD; Angela DeMichele, MD; and Erica L. Mayer, MD, MPH on behalf of the PALLAS groups and investigators

Journal of Clinical Oncology, 07 Dezember 2021, DOI: 10.1200/JCO.21.02554

The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)

Gunnar Folprecht, Anke Reinacher-Schick, Jürgen Weitz, Celine Lugnier, Anna-Lena Kraeft, Sarah Wisser, Daniela E. Aust, Lukas Weiss, Nikolas von Bubnoff, Michael Kramer, Christian Thiede, Andrea Tannapfel

Journal Clinical Colorectal Cancer, 9 November 2021, DOI: 10.1016/j.clcc.2021.09.005

Continuous vs intermittent extended adjuvant letrozole for breast cancer: Final results of randomized phase 3 SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.

Jerusalem G, Farah S, Courtois A, Chirgwin J, Aebi S, Karlsson P, Neven P, Hitre E, Graas MP, Simoncini E, Abdi E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O’Reilly S, Gombos A, Ruhstaller T, Burstein HJ, Rabaglio M, Ruepp B, Ribi K, Viale G, Gelber RD, Coates AS, Loi S, Goldhirsch A, Regan MM, Colleoni M. on behalf of the SOLE Investigators.

Annals of Oncology, October 2021; 32(10):1256-1266. DOI: 10.1016/j.annonc.2021.07.017.

ABCSG 48 / POSITIVE: Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri Fedro A. Peccatori, Hatem A. Azim Jr., Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Barbro Sætersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong Eon Lee, Janice M. Walshe, Manuel Ruíz Borrego, Halle CF. Moore, Christobel Saunders, Fatima Cardoso, Snezana Susnjar, Vesna Bjelic-Radisic, Karen L. Smith, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Olivia Pagani

The Beast, August 2021, DOI:

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer

Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler, Guenther G. Steger, Sigrun Greil-Ressler, Marija Balic, Dietmar Heck, Raimund Jakesz, Josef Thaler, Daniel Egle, Diether Manfreda, Vesna Bjelic-Radisic, Ursula Wieder, Christian F. Singer, Elisabeth Melbinger-Zeinitzer, Ferdinand Haslbauer, Paul Sevelda, Harald Trapl, Viktor Wette, Kerstin Wimmer, Simon P. Gampenrieder, Rupert Bartsch, Stephanie Kacerovsky-Strobl, Christoph Suppan, Christine Brunner, Christine Deutschmann, Lidija Soelkner, Christian Fesl, Richard Greil, on behalf of the Austrian Breast and Colorectal Cancer Study Group

N Engl J Med, 29 July 2021;385:395-405. DOI: 10.1056/NEJMoa2104162

Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative

Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum, Debora Fumagalli, Christos Sotiriou, Einav Nili Gal-Yam, Mark E Robson, Justin Ndozeng, Angelo Di Leo, Eva M Ciruelos, Evandro de Azambuja, Giuseppe Viale, Elsemieke D Scheepers, Giuseppe Curigliano, Judith M Bliss, Jorge S Reis-Filho, Marco Colleoni, Marija Balic, Fatima Cardoso, Joan Albanell, Caroline Duhem, Sandrine Marreaud, Dario Romagnoli, Beatriz Rojas, Andrea Gombos, Hans Wildiers, Angel GUERRERO-ZOTANO, Peter Hall, Andrea Bonetti, Karolina Fs Larsson, Martina Degiorgis, Silvia Khodaverdi, Richard Greil, Asgerdur Sverrisdottir, Marta Paoli, Ethel Seyll, Sybille Loibl, Barbro Linderholm, Gabriele Zoppoli, Nancy E Davidson, Oskar Th Johannsson, Philippe L Bedard, Sherene Loi, Susan Knox, David A Cameron, Nadia Harbeck, Maite Lasa Montoya, Mariana Brandão, Andrea Vingiani, Carmela Caballero, Florentine S Hilbers, Lucy R Yates, Matteo Benelli, David Venet and Martine J Piccart

Cancer Discovery June 28, 2021, doi: 10.1158/2159-8290.CD-20-1647

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial

Sibylle Loibl, Frederik Marmé, Miguel Martin, Michael Untch, Hervé Bonnefoi, Sung-Bae Kim, Harry Bear, Nicole McCarthy, Mireia Melé Olivé, Karen Gelmon, José García-Sáenz, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope S. Rugo, Carsten Denkert, Michael Gnant, Andreas Makris, Maria Koehler, Cynthia Huang-Bartelett, Maria Jose Lechuga Frean, Marco Colleoni, Gustavo Werutsky, Sabine Seiler, Nicole Burchardi, Valentina Nekljudova, and Gunter von Minckwitz

Journal of Clinical Oncology, 2021 May 10;39(14):1518-1530. doi: 10.1200/JCO.20.03639. Epub 2021 Apr 1.

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators.

N Engl J Med. June 3 2021 doi: 10.1056/NEJMoa2105215. Epub ahead of print. PMID: 34081848.

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34

Rupert Bartsch, Christian F. Singer , Georg Pfeiler, Michael Hubalek, Herbert Stoeger, Angelika Pichler, Edgar Petru, Vesna Bjelic-Radisic, Richard Greil8, Margaretha Rudas, Tea Maria Muy-Kheng, Viktor Wette, Andreas L. Petzer, Paul Sevelda, Daniel Egle, Peter C. Dubsky, Martin Filipits, Florian Fitzal, Ruth Exner , Raimund Jakesz, Marija Balic,Christoph Tinchon, Zsuzsanna Bago-Horvath, Sophie Frantal, Michael Gnant and for the Austrian Breast and Colorectal Cancer Study Group

British Journal of Cancer, March 2021

A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort

P.Dubsky, L.Van’t Veer, M.Gnant, M.Rudas, Z.Bago-Horvath, R.Greil, E.Lujinovic, J.Buresch, G.Rinnerthaler, W.Hulla, F.Moinfar, D.Egle, W.Herz, C.Dreezen, S.Frantal, M.Filipits

ESMO Open, Feb 2021

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

Erica L Mayer, Amylou C Dueck, Miguel Martin, Gabor Rubovszky, Harold J Burstein, Meritxell Bellet-Ezquerra, Kathy D Miller, Nicholas Zdenkowski, Eric P Winer, Georg Pfeiler, Matthew Goetz, Manuel Ruiz-Borrego, Daniel Anderson, Zbigniew Nowecki, Sibylle Loibl, Stacy Moulder, Alistair Ring, Florian Fitzal, Tiffany Traina, Arlene Chan, Hope S Rugo, Julie Lemieux, Fernando Henao, Alan Lyss, Silvia Antolin Novoa, Antonio C Wolff, Marcus Vetter, Daniel Egle, Patrick G Morris, Eleftherios P Mamounas, Miguel J Gil-Gil, Aleix Prat, Hannes Fohler, Otto Metzger Filho, Magdalena Schwarz, Carter DuFrane, Debora Fumagalli, Kathy Puyana Theall, Dongrui Ray Lu, Cynthia Huang Bartlett, Maria Koehler, Christian Fesl, Angela DeMichele, Michael Gnant,

The Lancet Oncology, Jan 2021,


Teilen auf